Read + Share
Luo C, Yu K, Luo X, Lian T, et al. CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for
HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis. BMC Cancer 2024;24:1031.
PMID: 39169295
|
 |
|
Luo C, Yu K, Luo X, Lian T, et al. CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for
HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis. BMC Cancer 2024;24:1031.
PMID: 39169295
|
|
|
|